Had stroke after the 1st and 2nd dose of the Moderna COVID 19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of CEREBROVASCULAR ACCIDENT (Had stroke after the 1st and 2nd dose of the Moderna COVID 19 vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Aug-2021, the patient experienced CEREBROVASCULAR ACCIDENT (Had stroke after the 1st and 2nd dose of the Moderna COVID 19 vaccine) (seriousness criterion medically significant). The patient was treated with ROSUVASTATIN at an unspecified dose and frequency; LEVETIRACETAM (KEPPRA [LEVETIRACETAM]) at an unspecified dose and frequency; EVOLOCUMAB (REPATHA) at an unspecified dose and frequency and APIXABAN (ELIQUIS) ongoing since an unknown date at an unspecified dose and frequency. At the time of the report, CEREBROVASCULAR ACCIDENT (Had stroke after the 1st and 2nd dose of the Moderna COVID 19 vaccine) outcome was unknown.            Treatment information was not provided.  The reporter stated that her husband had stroke on 23Jul2021 and 10Aug2021. He is taking Rosuvastatin, Keppra, Repatha and Eliquis. She stated that he had the stoke after getting the 1st and 2nd doses of the Moderna COVID 19 vaccine.  Company comment This spontaneous case concerns a male patient, of unknown age, with no relevant medical history reported, who experienced the unexpected, serious ADR of cerebrovascular accident (stroke). The date of administration of the second dose of the Moderna mRNA-1273 and the event start date were not provided. Very limited information was provided regarding the event. Of note, the reporter mentioned that her husband had a stroke on 23Jul2021 and 10Aug2021. Both events were reported to have occurred after receiving the first and second doses of the Moderna mRNA-1273 vaccine. The reporter also mentioned that the patient is taking Rosuvastatin, Keppra, Repatha and Eliquis. The rechallenge was not applicable for the second dose as no additional dosing will be given. The benefit-risk relationship of the Moderna mRNA-1273 is not affected by this report.   This case was linked to MOD-2021-391794 (Patient Link).; Sender's Comments: This spontaneous case concerns a male patient, of unknown age, with no relevant medical history reported, who experienced the unexpected, serious ADR of cerebrovascular accident (stroke). The date of administration of the second dose of the Moderna mRNA-1273 and the event start date were not provided. Very limited information was provided regarding the event. Of note, the reporter mentioned that her husband had a stroke on 23Jul2021 and 10Aug2021. Both events were reported to have occurred after receiving the first and second doses of the Moderna mRNA-1273 vaccine. The reporter also mentioned that the patient is taking Rosuvastatin, Keppra, Repatha and Eliquis. The rechallenge was not applicable for the second dose as no additional dosing will be given. The benefit-risk relationship of the Moderna mRNA-1273 is not affected by this report.